Summary
- The Supreme People's Court of China clarified the profit-based test for inventor remuneration in a landmark ruling on June 24, 2026, regarding a service invention dispute over a biosimilar patent.
- The court ordered a company to pay inventor Wang RMB 800,000, reversing a lower court's dismissal of his claims and establishing that remuneration is owed based on operating profit generated in specific years.
- This decision underscores the distinct obligations under Chinese patent law compared to U.S. law, particularly regarding statutory inventor compensation for service inventions.
- The ruling could reshape how companies approach inventor remuneration and profit-sharing in future patent disputes in China.
Join the discussion — sign up to comment, upvote, and save articles.